MEMORIAL SLOAN KETTERING CANCER CENTER REVENUE BONDS, 2019 SERIES 1 Dated: Date of Delivery Due: July 1, As Shown on Inside Cover

Total Page:16

File Type:pdf, Size:1020Kb

MEMORIAL SLOAN KETTERING CANCER CENTER REVENUE BONDS, 2019 SERIES 1 Dated: Date of Delivery Due: July 1, As Shown on Inside Cover NEW ISSUE Ratings: See “Ratings” herein. $284,545,000 DORMITORY AUTHORITY OF THE STATE OF NEW YORK ® MEMORIAL SLOAN KETTERING CANCER CENTER REVENUE BONDS, 2019 SERIES 1 Dated: Date of Delivery Due: July 1, as shown on inside cover Payment and Security: The Memorial Sloan Kettering Cancer Center Revenue Bonds, 2019 Series 1 (the “2019 Series 1 Bonds”) are special obligations of the Dormitory Authority of the State of New York (“DASNY”) payable from and secured by a pledge of (i) certain payments to be made under the Loan Agreement dated as of February 26, 2003, as amended (the “Loan Agreement”), between Memorial Sloan Kettering Cancer Center (the “Center”) and DASNY and Guaranties dated as of February 26, 2003 (the “Guaranties”), from the Sloan Kettering Institute for Cancer Research and S.K.I. Realty, Inc. to DASNY (the “Revenues”) and (ii) all funds and accounts (excluding the Arbitrage Rebate Fund and any fund established for the payment of the Purchase Price of Option Bonds tendered for purchase) established under DASNY’s Memorial Sloan Kettering Cancer Center Revenue Bond Resolution adopted February 26, 2003 (the “General Resolution”) and the 2019 Series 1 Resolution, adopted September 11, 2019 (the “Series Resolution” and together with the General Resolution, the “Resolution”). The Loan Agreement is a general, unsecured obligation of the Center and requires the Center to pay, in addition to the fees and expenses of DASNY and the Trustee, amounts sufficient to pay the principal and Redemption Price of and interest on all Bonds issued under the Resolution, including the 2019 Series 1 Bonds, as such payments become due. The 2019 Series 1 Bonds are not a debt of the State of New York (the “State”), nor is the State liable thereon. DASNY has no taxing power. Description: The 2019 Series 1 Bonds will be issued as fully registered bonds in denominations of $5,000 and any integral multiple thereof. Interest (due January 1, 2020 and each January 1 and July 1 thereafter) will be payable by check or draft mailed to the registered owners of the 2019 Series 1 Bonds at their addresses as shown on the registration books held by the Trustee or, at the option of a holder of at least $1,000,000 in principal amount of 2019 Series 1 Bonds, by wire transfer to the holder of such 2019 Series 1 Bonds, each as of the close of business on the fifteenth day of the month next preceding an interest payment date. The principal or Redemption Price of the 2019 Series 1 Bonds will be payable at the principal corporate trust office of The Bank of New York Mellon New York, New York, the Trustee and Paying Agent (as defined herein) or, with respect to Redemption Price, at the option of a holder of at least $1,000,000 in principal amount of 2019 Series 1 Bonds, by wire transfer to the holders of such 2019 Series 1 Bonds as more fully described herein. The 2019 Series 1 Bonds will be issued initially under a Book‑Entry Only System, registered in the name of Cede & Co., as nominee for The Depository Trust Company (“DTC”). Individual purchases of beneficial interests in the 2019 Series 1 Bonds will be made in Book‑Entry form (without certificates). So long as DTC or its nominee is the registered owner of the 2019 Series 1 Bonds, payments of the principal and Redemption Price of and interest on such 2019 Series 1 Bonds will be made directly to DTC or its nominee. Disbursement of such payments to DTC participants is the responsibility of DTC and disbursement of such payments to the beneficial owners is the responsibility of DTC participants. See “PART 3 ‑ THE 2019 SERIES 1 BONDS ‑ Book‑Entry Only System” herein. Tender for Purchase and Redemption: The 2019 Series 1 Bonds are subject to redemption, tender or purchase prior to maturity, as more fully described herein. Tax Exemption: In the opinion of Orrick, Herrington & Sutcliffe LLP (“Orrick”), based upon an analysis of existing laws, regulations, rulings and court decisions, and assuming, among other matters, the accuracy of certain representations and compliance with certain covenants, interest on the 2019 Series 1 Bonds is excluded from gross income for federal income tax purposes under Section 103 of the Internal Revenue Code of 1986 (the “Code”). In the further opinion of Orrick, interest on the 2019 Series 1 Bonds is not a specific preference item for purposes of the federal alternative minimum tax. Orrick is also of the opinion that interest on the 2019 Series 1 Bonds is exempt from personal income taxes imposed by the State of New York and any political subdivision thereof (including The City of New York). Orrick expresses no opinion regarding any other tax consequences related to the ownership or disposition of, or the amount, accrual or receipt of interest on, the 2019 Series 1 Bonds. See “PART 11 ‑ TAX MATTERS” herein. Except as set forth in “PART 3 – THE 2019 SERIES 1 BONDS,” this Official Statement does not describe (i) any other interest rate mode into which the 2019 Series 1 Bonds may be converted, (ii) any provision relating to the tender provisions applicable to the 2019 Series 1 Bonds after any such conversion, or (iii) the remarketing of the 2019 Series 1 Bonds upon any such conversion and the application of the proceeds thereof. A remarketing of the 2019 Series 1 Bonds upon any such conversion will be made solely by a separate offering document or through a private placement to a limited number of institutional investors and not by this Official Statement. MATURITY SCHEDULE – See Inside Cover Page The 2019 Series 1 Bonds maturing July 1, 2035 through July 1, 2039, inclusive (the “Negotiated Bonds”), are offered when, as and if issued and received by the Underwriters. The 2019 Series 1 Bonds maturing July 1, 2029 through July 1, 2034, inclusive (the “Competitive Bonds”), are being sold through a competitive auction bid process in accordance with a Notice of Sale dated October 3, 2019. The offer of the 2019 Series 1 Bonds may be subject to prior sale, or may be withdrawn or modified at any time without notice. The offer is subject to the approval of legality by DASNY’s Co‑Bond Counsel, Orrick, Herrington & Sutcliffe LLP, New York, New York and Marous Law Group, P.C., New York, New York and to certain other conditions. Certain legal matters will be passed upon for the Underwriters of the Negotiated Bonds and the Initial Purchaser of the Competitive Bonds by their counsel, Katten Muchin Rosenman LLP, New York, New York; and for the Center and its related corporations by its counsel, Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York. DASNY expects to deliver the 2019 Series 1 Bonds in definitive form in New York, New York, on or about November 1, 2019. Goldman Sachs & Co. LLC BofA Merrill Lynch J.P. Morgan Morgan Stanley UBS Dated October 8, 2019 as supplemented on October 10, 2019 to include the terms of and information with respect to the Negotiated Bonds. PRINCIPAL AMOUNTS, INTEREST RATES AND YIELDS OR PRICES $284,545,000 2019 Series 1 Bonds Maturity Principal Interest July 1 Amount Rate Yield CUSIP† 20291 $21,775,000 5.000% 1.410% 64990GUW0 20301 22,865,000 5.000 1.450C 64990GUX8 20311 24,005,000 4.000 1.650C 64990GUY6 20321 24,970,000 4.000 1.630C 64990GUZ3 20331 25,960,000 2.000 2.235 64990GVA7 20341 26,485,000 3.000 2.130C 64990GVB5 20352 25,220,000 5.000 1.780C 64990GVC3 20362 26,475,000 5.000 1.840C 64990GVD1 20372 27,800,000 4.000 2.100C 64990GVE9 20382 28,915,000 4.000 2.140C 64990GVF6 20392 30,075,000 5.000 1.980C 64990GVG4 † The CUSIP number has been assigned by an independent company not affiliated with DASNY and is included solely for the convenience of the owners of the 2019 Series 1 Bonds. DASNY is not responsible for the selection or uses of the CUSIP number, and no representation is made as to its correctness on the 2019 Series 1 Bonds or as indicated above. The CUSIP number is subject to being changed after the issuance of the 2019 Series 1 Bonds as a result of various subsequent actions including, but not limited to, a refunding of a portion of the 2019 Series 1 Bonds 1 Competitive Bond sold to the Initial Purchaser pursuant to the Notice of Sale. 2 Negotiated Bond sold to the Underwriters. C Priced at the stated yield to the July 1, 2029 optional redemption date at a Redemption Price equal to 100% of the principal amount of the 2019 Series 1 Bonds or portions thereof to be redeemed, plus accrued interest, if any, to the redemption date. No dealer, broker, salesperson or other person has been authorized by DASNY, MSKCC (defined herein), the Underwriters or the Initial Purchaser to give any information or to make any representations with respect to the 2019 Series 1 Bonds, other than the information and representations contained in this Official Statement. If given or made, any such information or representations must not be relied upon as having been authorized by DASNY, MSKCC, the Underwriters or the Initial Purchaser. This Official Statement does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be a sale of the 2019 Series 1 Bonds by any person in any jurisdiction in which it is unlawful for such person to make such offer, solicitation or sale.
Recommended publications
  • JANUARY 2017 | VOLUME 102 NUMBER 1 | AMERICAN COLLEGE of SURGEONS Bulletin Contents
    JANUARY 2017 | VOLUME 102 NUMBER 1 | AMERICAN COLLEGE OF SURGEONS Bulletin Contents FEATURES COVER STORY: Reimbursement changes in 2017 The 2017 Medicare physician fee schedule: An overview of provisions that will affect surgical practice 11 Lauren Foe, MPH; Jan Nagle, MS, RPh; and Vinita Ollapally, JD 2017 CPT coding changes 16 Albert Bothe, MD, FACS; Megan McNally, MD, FACS; and Jan Nagle, MS, RPh Profiles in surgical research: Mary T. Hawn, MD, MPH, FACS 26 Juliet A. Emamaullee, MD, PhD, FRCSC, and Kamal M. F. Itani, MD, FACS The 2016 RAS-ACS annual Communications Committee essay contest: An introduction 33 Erin Garvey, MD | 1 First-place essay: Paying it forward: When the mentee becomes the mentor 34 Kevin Koo, MD, MPH, MPhil Highlights of Clinical Congress 2016 35 ACS Officers, Regents, and Board of Governors’ Executive Committee 46 JAN 2017 BULLETIN American College of Surgeons Contents continued COLUMNS A look at The Joint Commission: ASCPA-SurgeonsPAC makes an Annual report provides details impact on 2016 congressional Looking forward 8 on patient safety, quality elections 80 David B. Hoyt, MD, FACS improvements 69 Katie Oehmen ACS NSQIP Best Practices case Carlos A. Pellegrini, MD, Call for nominations for the ACS studies: Impact of SSI reduction FACS, FRCSI(Hon), FRCS(Hon), Board of Regents and ACS strategy after colorectal resection 49 FRCSEd(Hon) Officers-Elect 82 Lisa A. Wilbert, RN NTDB data points: Annual Report Nominations for 2017 Dispatches from rural surgeons: 2016: Almost a 10 71 volunteerism and humanitarian Rural surgery: High pressure Richard J. Fantus, MD, FACS awards due February 28 84 but rewarding 55 Report on ACSPA/ACS activities, Susan Long, MD, FACS NEWS October 2016 86 From residency to retirement: In memoriam: Jay L.
    [Show full text]
  • Upper West Side / Central Park
    Upper West Side / Central Park Streets West 87 Street, K4-8 West 107 Street, A3-8 Beresford Apartments, The, M8 Summit Rock, M9 Contemporary African Art Gallery, A3 Greystone Hotel, H5 JHS 54, A7 Nicholas Roerich Museum, A3 Riverside Montessori School, G3 St. Ignatius Episcopal Church, K4 Symphony Space, G4 Subway Stations Amsterdam Avenue, A-M5 West 88 Street, J4-8 West 108 Street, A3-8 Bloomingdale Playground, B6 Tennis Courts, F10 Days Hotel, G5 Grosvenor Neighborhood House Kateri Residence, K2 Normandy Apartments, K2 Riverside Park, A2-M2 St. Mary Magdalen Orth. Church, A7 Thalia Theater, F4 81 St-Musuem of Natural History Key Broadway, A4, E-M5 West 89 Street, J4-8 West Drive, B10, F9, M9 Bloomingdale Public Library, D6 The Loch, C11 De La Salle Academy, F5 YMCA, B6 La Perla Community Garden, B7 Open Door Child Care Center, D7 Beach Volleyball Courts, B2 St. Matthew & St. Timothy Trinity Lutheran Church, D6 BC, M9 accessible Central Park West, A-M8 West 90 Street (Henry J. West End Avenue, A-M4 Brandon Residence for Women, L3 The Pool, C9 Douglass Houses, C6, C7 Harcourt Residence Hotel, F4 Louis Brandeis High School, L6 Park West Montessori School, C8 Crabapple Grove Garden, G2 Episcopal Church, L7 Trinity School, H6 86 St 1, K5 entrance & exit Columbus Avenue, A-M7 Browne Blvd), J4-8 Bretton Hall, L5 Central Park Hostel, C8 Dwight School, J8 Head Start, A6, C4, C7, F7, H7, K6 Malibu Studios Hotel, C5 Park West Village, E6, E7 Dinosaur Playground, E2 St. Matthew’s & St. Timothy’s Ukrainian Orthodox Church, M6 86 St , K9 Subway station and BC exits Duke Ellington Blvd West 91 Street, H4-8 Points of Interest Brewster Hotel, K8 Chabad Lubavitch of the West Side, G6 Edward A.
    [Show full text]
  • TOWERS NURSING HOME, 2 West 106Th Street
    .. - Landmarks Preservation Colmlission August 17, 1976, Number I LP-0938 TOWERS NURSING HOME, 2 West 106th Street. 32 West 106th Street and 455 Central Park West. Borough of Manhattan. Original building, 1884-86; additions. 1889-90. and 1925-26; outbui !ding, 1886-87; architect Charles Coolidge Haight. Landmark Site: Borough of Manhattan Tax Map Block 1841, Lot 25. On July 13, 1976, the Landmarks Preservation Commission held a public · hearing on the proposed designation as a Landmark of the Towers Nursing Home and the proposed designation of the related Landmark Site (Item No. 9). The hearing had been duly advertised in accordance with the provisions of law. Twenty-one witnesses spoke in favor of designation. There were two speakers in opposition to designation. The Commission has also received many letters and other expressions of support in favor of designation. A number of letters have been received in opposition to designation. DESCRIPTION AND ANALYSIS The Towers Nursing Home, originally the New York Cancer Hospital, was built in three sections between 1884 and 1890 from plans by the noted New York City architect Charles Coolidge Haight. Prominently located at the wide · intersection of Centra·l Park West and West 106th Street, the Towers is a toea I point for the surrounding neighborhood, and with its towers crowned by conical roofs, is one of the most distinguished buildings facing Central Park. The New York Cancer Hospital was founded in 1884 to further the study and treatment of cancer. In 1882 John Jacob Astor had made an offer to the Woman's Hospital to fund a pavilion for the treatment of cancer patients.
    [Show full text]
  • 281165000 Dormitory Authority of the State Of
    NEW ISSUE Moody’s: “Aa2” Standard & Poor’s: “AA” FitchRatings: “AA” (See “Ratings” herein) $281,165,000 DORMITORY AUTHORITY OF THE STATE OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER REVENUE BONDS, SERIES 2008A2 Dated: Date of Delivery Due: July 1, as shown on inside cover Payment and Security: The Memorial Sloan-Kettering Cancer Center Revenue Bonds, Series 2008A2 Bonds (the “Series 2008A2 Bonds”) are special obligations of the Dormitory Authority of the State of New York (the “Authority”) payable from and secured by a pledge of (i) certain payments to be made under the Loan Agreement (the “2002 Loan Agreement”), dated as of December 5, 2001, as amended, between Memorial Sloan-Kettering Cancer Center (the “Center”) and the Authority and Guaranties (the “Guaranties”), dated as of December 5, 2001, from the Sloan-Kettering Institute for Cancer Research and S.K.I. Realty, Inc. to the Authority (the “Revenues”) and (ii) all funds and accounts (excluding the Arbitrage Rebate Fund and any fund established for the payment of the Purchase Price of Option Bonds tendered for purchase) established under the Authority’s Memorial Sloan-Kettering Cancer Center Revenue Bond Resolution adopted December 5, 2001 and the Series 2008A Resolution adopted March 26, 2008 (collectively, the “Resolution”). The 2002 Loan Agreement is a general, unsecured obligation of the Center and requires the Center to pay, in addition to the fees and expenses of the Authority and the Trustee, amounts sufficient to pay the principal and Redemption Price of and interest on all Bonds issued under the Resolution, including the Series 2008A2 Bonds, as such payments become due.
    [Show full text]
  • Oncology Standardization Challenge -OHDSI Solution -MSK Implementation
    -Oncology Standardization Challenge -OHDSI Solution -MSK Implementation MITRE Community Presentation Rimma Belenkaya, MSK June 26, 2020 Introduction Rimma Belenkaya Head of Knowledge Management Team Memorial Sloan Kettering Cancer Center (MSK) MSK is a cancer treatment and research institution in New York City, founded in 1884 as the New York Cancer Hospital. It is the largest and oldest private cancer center in the world, and is one of 70 NCI- designated Comprehensive Cancer Centers. Co-Lead of OHDSI Oncology Workgroup OHDSI (formerly OMOP) stands for Observational Health Data Sciences and Informatics collaborative founded in 2009 with a base at Columbia University. OHDSI community conducts research on a global scale using standardized representations of health care data and reproducible standardized open source analytics. The challenges of Real-World Data OMOP Common Data Model (CDM) Version 6 OMOP Vocabulary • Incorporate (=re-use), don’t invent • Selected by – Comprehensiveness – Quality – Ontological principles: Concepts, life cycle, existing relationships to other • Use Open Source, give credit • Incorporate, disambiguate, map Generating Reliable Evidence 2015 – NYC-CDRN Success • Standardized data of 7 mln patient from 6 major New York hospitals to OMOP • Data are used for comparative effectiveness research and cohort selection for prospective studies • • • 2016 - MSK Data Challenge Lack of standardized data precludes or makes challenging • Cohort generation for clinical studies • Data integration to support analysis and research
    [Show full text]
  • MEMORIAL SLOAN KETTERING CANCER CENTER REVENUE BONDS, 2017 SERIES 1 Dated: Date of Delivery Due: July 1, As Shown on Inside Cover
    NEW ISSUE Ratings: See “Ratings” herein. $294,420,000 DORMITORY AUTHORITY OF THE STATE OF NEW YORK ® MEMORIAL SLOAN KETTERING CANCER CENTER REVENUE BONDS, 2017 SERIES 1 Dated: Date of Delivery Due: July 1, as shown on inside cover Payment and Security: The Memorial Sloan Kettering Cancer Center Revenue Bonds, 2017 Series 1 (the “2017 Series 1 Bonds”) are special obligations of the Dormitory Authority of the State of New York (“DASNY”) payable from and secured by a pledge of (i) certain payments to be made under the Loan Agreement (the “Loan Agreement”), dated as of February 26, 2003, between Memorial Sloan Kettering Cancer Center (the “Center”) and DASNY and Guaranties (the “Guaranties”), dated as of February 26, 2003, from the Sloan Kettering Institute for Cancer Research and S.K.I. Realty, Inc. to DASNY (the “Revenues”) and (ii) all funds and accounts (excluding the Arbitrage Rebate Fund and any fund established for the payment of the Purchase Price of Option Bonds tendered for purchase) established under DASNY’s Memorial Sloan Kettering Cancer Center Revenue Bond Resolution adopted February 26, 2003 (the “2003 Resolution”) and the 2017 Series 1 Resolution, adopted November 29, 2017 (the “Series Resolution” and together with the 2003 Resolution, the “Resolution”). The Loan Agreement is a general, unsecured obligation of the Center and requires the Center to pay, in addition to the fees and expenses of DASNY and the Trustee, amounts sufficient to pay the principal and Redemption Price of and interest on all Bonds issued under the Resolution, including the 2017 Series 1 Bonds, as such payments become due.
    [Show full text]
  • Eustace Mullins
    MURDER BY INJECTION The Story of the Medical Conspiracy Against America By EUSTACE MULLINS The National Council for Medical Research P.O. Box 1105 Staunton, Virginia 24401 1 MURDER BY INJECTION The Story of the Medical Conspiracy Against America First Edition Library of Congress Card Catalog No. 88-060694 Copyright © 1988 Eustace Mullins ALL RIGHTS RESERVED No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means—electronic, mechanical, photocopy, recording, or otherwise—without express prior permission, with the exception of brief excerpts in magazine articles and/or reviews. Printed in the United States of America 2 For BLAIR in appreciation of your unequalled dedication to American ideals 3 Contents 1. The Medical Monopoly 1 2. Quacks on Quackery 13 3. The Profits of Cancer 59 4. Death and Vaccination 129 5. The Fluoridation Conspiracy .148 6. Whither AIDS 169 7. The Action of Fertilizers 187 8. Contamination of the Food Supply 204 9. The Drug Trust 226 10. The Rockefeller Syndicate 310 4 Foreword The present work, the result of some forty years of investigative research, is a logical progression from my previous books: the expose of the international control of monetary issue and banking practices in the United States; a later work revealing the secret network of organizations through which these alien forces wield political power—the secret committees, foundations, and political parties through which their hidden plans are implemented; and now; to the most vital issue of all, the manner in which these depredations affect the daily lives and health of American citizens.
    [Show full text]
  • Brief Biographies of American Architects Who Died Between 1897 and 1947
    Brief Biographies of American Architects Who Died Between 1897 and 1947 Transcribed from the American Art Annual by Earle G. Shettleworth, Jr., Director, Maine Historic Preservation Commission. Between 1897 and 1947 the American Art Annual and its successor volume Who's Who in American Art included brief obituaries of prominent American artists, sculptors, and architects. During this fifty-year period, the lives of more than twelve-hundred architects were summarized in anywhere from a few lines to several paragraphs. Recognizing the reference value of this information, I have carefully made verbatim transcriptions of these biographical notices, substituting full wording for abbreviations to provide for easier reading. After each entry, I have cited the volume in which the notice appeared and its date. The word "photo" after an architect's name indicates that a picture and copy negative of that individual is on file at the Maine Historic Preservation Commission. While the Art Annual and Who's Who contain few photographs of the architects, the Commission has gathered these from many sources and is pleased to make them available to researchers. The full text of these biographies are ordered alphabetically by surname: A B C D E F G H I J K L M N O P Q R S T U V W Y Z For further information, please contact: Earle G. Shettleworth, Jr., Director Maine Historic Preservation Commission 55 Capitol Street, 65 State House Station Augusta, Maine 04333-0065 Telephone: 207/287-2132 FAX: 207/287-2335 E-Mail: [email protected] AMERICAN ARCHITECTS' BIOGRAPHIES: ABELL, W.
    [Show full text]
  • The New York Cancer Hospital
    The New York Cancer Hospital, Eighth Ave. and 106th Street, New York City. Incorporated May 31, 1884. Opened for the Admission of Patients, December 7, 1887. THE NEWYORK CANCER HOSPITAL. The pavilion erected for female patients was opened on December 7th, 1887. Since that date there have been in the Hospital 461 patients, of whom 153 have been discharged cured, 127 benefitted, 60 unimproved. 87 have died, and 34 remain at the present time at the Hospital. Of those who have died the great majority were chronic cases. During the time that they were in the Hospital they had the benefit of the most careful attention and treatment, greatly ameliorating their condition. The Hospital is in part supported by the income of an invested fund, and receipts from pay patients. In addition to this there is required an annual expenditure of at least $25,000. Thus far the undertaking has been generously helped by the gifts of a limited number of benefactors who were familiar with the object and scope of the institution. The Trustees are encouraged to believe that now that the work of the Hospital is more widely known, the means will be furnished to meet its necessities. The occasion for such a Hospital has been acknowledged by the high- est medical authorities. Its advantages will be appreciated by all. It will supplement the work of our general hospitals, and being devoted exclusively to cancer, it will offer the best possible opportunities for its treatment. One of its objects is to test and compare the result of different methods of treat- ment, to collect statistics for study by an accurate observation of a large number of cases, and to give to patients the benefit of the best treatment which observation and experience are able to supply.
    [Show full text]
  • Landmarks Reimagined Home & Estates Magazine
    January 2019 Homes & Estates Magazine By Roger Grody Circulation: N/A Landmarks Reimagined AFTER YEARS OF NEGLECT, SOME OF AMERICA’S GREAT ARCHITECTURAL TREASURES ARE RETURNED TO LIFE WITH LUXURY IN MIND. BY ROGER GRODY RENDERING BY NAVIN PATHANGAY, AIA PATHANGAY, RENDERING BY NAVIN einventing aging, often forgotten build- ings — restaurants ensconced in old churches or chic lofts carved out of former factories — not only preserves our history but creates energy in pre- Rviously neglected neighborhoods. This trend of “adap- tive reuse” extends to the luxury market as well, with elegant residences and fi ve-star hotels occupying unexpected old structures. Like Rolls-Royce or Cartier, the very name Ritz-Carlton exudes luxury, and most of the brand’s properties are stately structures or gleaming towers. But The Ritz-Carlton George- town, Washington, D.C., located in one of the city’s most desirable neighborhoods, occupies a former incinerator. In 2003, the long-neglected 1932 land- mark debuted as a mixed-use project that includes the 86-room luxury hotel, 28 Ritz-Carlton-branded residences (with prices approaching $14 million) and a theater complex. Citing the building’s unique industrial heritage, hotel general manager Marcus A. Loevenforst states, “There are many distinct features that set us apart from other hotels in the Ritz-Carlton portfolio.” The award-winning project, designed by New York-based Handel Architects, has become popular not only with 6 | Homes & Estates January 2019 Homes & Estates Magazine An 1884 hospital, long neglected, was repurposed into one of Manhattan’s premier residential addresses. PHOTOS BY JOHN BARTELSTONE PHOTOGRAPHY PHOTOS BY JOHN BARTELSTONE preservationists but sophisticated travelers as well.
    [Show full text]
  • Appendix EE.09 – Cultural Resources
    Appendix EE.09 – Cultural Resources Tier 1 Final EIS Volume 1 NEC FUTURE Appendix EE.09 - Cultural Resources: Data Geography Affected Environment Environmental Consequences Context Area NHL NRHP NRE NHL NRHP NRE NHL NRHP NRE NHL NRHP NRE NHL NRHP NRE NHL NRHP NRE State County Existing NEC including Existing NEC including Existing NEC including Preferred Alternative Preferred Alternative Preferred Alternative Hartford/Springfield Line Hartford/Springfield Line Hartford/Springfield Line DC District of Columbia 10 21 0 10 21 0 0 3 0 0 4 0 49 249 0 54 248 0 MD Prince George's County 0 7 0 0 7 0 0 0 0 0 2 0 1 23 0 1 23 0 MD Anne Arundel County 0 3 0 0 3 0 0 0 0 0 1 0 0 8 0 0 8 0 MD Howard County 0 1 0 0 1 0 0 0 0 0 0 0 1 3 0 1 3 0 MD Baltimore County 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 10 0 MD Baltimore City 3 44 0 3 46 0 0 1 0 0 5 0 25 212 0 26 213 0 MD Harford County 0 5 0 0 7 0 0 0 0 0 2 0 1 12 0 1 15 0 MD Cecil County 0 6 2 0 8 2 0 0 2 0 1 2 0 11 2 0 11 2 DE New Castle County 3 64 2 3 67 2 0 2 1 0 5 2 3 187 1 4 186 2 PA Delaware County 0 4 0 1 5 0 0 0 0 0 0 0 1 18 0 1 18 0 PA Philadelphia County 9 85 1 10 87 1 0 2 1 3 4 1 57 368 1 57 370 1 PA Bucks County 3 8 1 3 8 1 0 1 1 1 1 1 3 15 1 3 15 1 NJ Burlington County 0 0 0 0 0 0 0 0 0 0 0 0 1 17 0 1 17 0 NJ Mercer County 1 9 1 1 10 1 0 0 2 0 0 2 5 40 1 6 40 1 NJ Middlesex County 1 20 2 1 20 2 0 0 1 0 1 1 1 42 2 1 42 2 NJ Somerset County 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 4 0 NJ Union County 1 9 1 1 10 1 0 1 1 0 2 1 2 17 1 2 17 1 NJ Essex County 1 24 1 1 26 1 0 1 1 0 1 1 1 65 1 1 65 1 NJ Hudson County
    [Show full text]
  • Murder by Injection
    MURDER BY INJECTION The Story of the Medical Conspiracy Against America By EUSTACE MULLINS The National Council for Medical Research P.O. Box 1105 Staunton, Virginia 24401 MURDER BY INJECTION The Story of the Medical Conspiracy Against America First Edition Library of Congress Card Catalog No. 88-060694 Copyright © 1988 Eustace Mullins ALL RIGHTS RESERVED No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means--electronic, mechanical, photocopy, recording, or otherwise--without express prior permission, with the exception of brief excerpts in magazine articles and/or reviews. Printed in the United States of America For BLAIR in appreciation of your unequalled dedication to American ideals Eustace Mullins – Murder By Injection Page 1 Contents 1. The Medical Monopoly -------------------------------------------------- 06 2. Quacks on Quackery ---------------------------------------------------- 13 3. The Profits of Cancer ---------------------------------------------------- 40 4. Death and Vaccination -------------------------------------------------- 80 5. The Fluoridation Conspiracy ------------------------------------------- 91 6. Whither AIDS ------------------------------------------------------------ 104 7. The Action of Fertilizers ------------------------------------------------ 115 8. Contamination of the Food Chain ------------------------------------ 125 9. The Drug Trust ----------------------------------------------------------- 138 10. The Rockefeller Syndicate
    [Show full text]